Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-18

Clinical Trial Update: A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled trial of quetiapine for anorexia nervosa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: University of South Florida | Conditions: Anorexia Nervosa | Phase 2 | Status: TERMINATED